Document is current
Any future updates will be listed below
-
Authors
Dörr, Nicoletta https://orcid.org/0009-0001-5017-5824
Hüsing, Thea https://orcid.org/0009-0006-5022-1671
Kleespies, Hanna
Holtkamp, Martin https://orcid.org/0000-0003-2258-1670
Doerrfuss, Jakob I. https://orcid.org/0000-0002-8682-0215
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 31 March 2026
Revised: 23 May 2026
Accepted: 26 May 2026
First Online: 9 June 2026
Declarations
:
: ND declares no conflict of interest related to the manuscript. TH received travel costs from Jazz Pharmaceuticals. HK declares no conflict of interest related to the manuscript. JID reports personal fees from Eisai within the last 3 years, outside the submitted work. MH reports personal fees from Angelini, Bial, Danone, Desitin, Eisai, Jazz Pharma, Neuraxpharm, and UCB within the last 3 years, outside the submitted work.
: The study was approved by the local ethics committee of Charité Universitätsmedizin Berlin (EA2/181/20) and conducted in accordance with the Declaration of Helsinki and relevant institutional guidelines. Due to the retrospective nature of the study, the requirement for written informed consent was waived. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.
